Publication

Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

Graph Chatbot

Chat with Graph Search

Repositioning approved drugs for the treatment of problematic cancers using a screening approach

Enhanced Rate of Acquisition of Point Mutations in Mouse Intestinal Adenomas Compared to Normal Tissue

Mapping mitochondrial heteroplasmy in a Leydig tumor by laser capture microdissection and cycling temperature capillary electrophoresis

Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival?

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation

Role of RIP4 in lung adenocarcinoma differentiation

The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression

MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes

Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-beta-D-ribose Oxidase